2021 Virtual Late Fall Meeting- Tuesday November 9th 5-7PM 

To register for the meeting please use the link below. 

 https://cap-org.zoom.us/webinar/register/WN_cFmYKom3T86503WQSqdA7Q [cap-org.zoom.us].

 

Meeting agenda 

Time: 5-5:15 PM:

Business Meeting

 

Time: 5:15 -6PM

 

Lecture:  CAP/MSP Pathology advocacy update 

Faculty: Dr. Emily Volk, President College of American Pathologists

Chief Medical Officer, Baptist Health Floyd , New Albany, Indiana

 

Time: 6-7 PM

 

 

 

 

 

Lecture: Updates from the WHO Soft Tissue and Bone Tumours 5th Edition

Faculty: Dr. Jerad Gardner

Dermatopathologist & Section Head of Bone/Soft Tissue Pathology
Geisinger Medical Center, Danville, Pennsylvania, USA

 At the end of this activity participants should be able to:

  • Understand how to distinguish “atypical spindle cell/pleomorphic lipomatous tumor” from liposarcoma
  • Recognize “superficial CD34 positive fibroblastic tumor” and distinguish it from pleomorphic sarcoma
  • Apply risk stratification to better predict prognosis of solitary fibrous tumor

 

Joint Providership Accreditation Statement:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the College of American Pathologists and Massachusetts Society of Pathologists. The College of American Pathologists is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement; The College of American Pathologists designates this internet live educational activity for a maximum of 1AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclaimer
The content of this CME activity does not necessarily reflect the view or policies of the College of American Pathologists

Disclosure Information

All authors/speakers/planners/reviewers of a CAP educational activity must disclose to the program audience any financial interest or relationship with any proprietary entity producing, marketing, reselling or distributing health care goods  or services consumed by, or used on patients that may be discussed in the educational activity or with any proprietary entity producing, marketing, reselling or distributing health care goods or services consumed by, or used on patients that is directly competitive with a product discussed in the presentation. Relevant financial relationships are considered to be any financial relationships in any amount occurring within the past 12 months that create a conflict of interest.

 

The College of American Pathologists does not view the existence of these interests or uses as implying bias or decreasing the value to participants.  The CAP, along with the Accreditation Council for Continuing Medical Education (ACCME), feels that this disclosure is important for the participants to form their own judgment about each presentation.  Below you will find the financial disclosure relationships for anyone who was able to affect content of this educational activity.

 

The CAP does identify and manage all potential conflicts of interest to ensure that all educational activities promote improvements or quality in healthcare and are free of commercial bias for or against a product/service.